Search

Matthias Pfisterer Drug-eluting stents and their additional benefit to low-risk patients were investigated in a cost-effectiveness analysis presented to the Stockholm cardiology meeting by Matthias Pf

Freek Verheugt Shamir Mehta of McMaster University told Audio Medica in Stockholm about the OASIS-5/MICHELANGELO results comparing the new anti-thrombotic therapy, fondaparinux, with enoxaparin among

Reporting from: – American Society of Hematology 46th Annual Meeting, December 4-7, 2004, San Diego – San Antonio Breast Cancer Symposium, December 8-11, 2004 – Gastrointestinal Canc

Reporting from: American College of Cardiology Annual Scientific Session 2005, March 6-9, Orlando, Florida In this edition: Adnan Kastrati has found that a study comparing the two main drug eluting st

Reporting from: – Annual Meeting of the American Society of Hematology, December 4-7, 2004, San Diego – Chemotherapy Foundation Symposium, November 10-13 2004, New York – European So

Reporting from: American Heart Association Scientific Sessions, New Orleans, November 7-10, 2004 In this edition: In severe heart failure, Teresa De Marco told delegates at the American Heart Associat

Reporting from: – European Society for Medical Oncology Congress, October 29-November 10, 2004, Vienna – Journal of Clinical Oncology – New England Journal of Medicine – Lancet

Reporting from: – 4th European Breast Cancer Conference, March 16-20, 2004, Hamburg – 6th International Symposium on Hodgkin’s Lymphoma – 16th EORTC-NCI-AACR Symposium on Molec

Reporting from: – 40th Annual Meeting of the American Society of Clinical Oncology, New Orleans, June 5-8, 2004 – New England Journal of Medicine – Journal of Clinical Oncology &#821

Reporting from: – 40th Annual Meeting of the American Society of Clinical Oncology, New Orleans, June 5-8, 2004 – New England Journal of Medicine In this edition: At the ASCO conference Ga

Reporting from: European Society of Cardiology Congress, Munich, August 28-1 September, 2004 In this edition: The RITA-3 trial – focussing on how to manage patients with acute coronary syndromes